Advertisement
Loading...

Novartis AG

NVSEF•PNK
Healthcare
Drug Manufacturers - General
$142.65
$0.00(0.00%)
U.S. Market is Open • 15:34

Novartis AG (NVSEF) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap272.2B
P/E Ratio20.18
EPS (TTM)$6.98
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 Month$147.85
3 Months$178.42
1 Year Target$160.27

NVSEF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVSEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $160.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.18 and a market capitalization of 272.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-2.13%
1-Month Change
-5.53%
3-Month Change
-14.24%
6-Month Change
15.33%
Year-to-Date (YTD) Change
3.37%
1-Year Change
33.94%
3-Year Change
46.11%
5-Year Change
63.53%
All-Time (Max) Change
254.41%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

75,883 Employees
IPO DateApr 26, 2010
CountryCH
Actively Trading

Frequently Asked Questions